Advertisement
Screener

Enovis Corp (ENOV) Other Nonoperating Income (Expense)

2.1 / 5 stars · 44/106 Roast Me

Enovis Corp Other Nonoperating Income (Expense)

Enovis Corp (ENOV) reported Other Nonoperating Income (Expense) of -$1.91 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Other Income

us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-06

  • Enovis Corp other nonoperating income (expense) for the quarter ending 2026-07-03 was -$1.91M, a 538.07% decline year-over-year.
  • Enovis Corp other nonoperating income (expense) for the quarter ending 2026-04-03 was $3.27M.
  • Enovis Corp other nonoperating income (expense) for the quarter ending 2025-12-31 was $141.00K, a 53.26% increase year-over-year.
  • Enovis Corp other nonoperating income (expense) for the quarter ending 2025-10-03 was $448.00K, a 121.78% increase year-over-year.
  • Enovis Corp other nonoperating income (expense) for fiscal 2025 was -$367.00K, a 103.71% decline from fiscal 2024.
  • Enovis Corp other nonoperating income (expense) for fiscal 2024 was $9.89M, a 61.44% decline from fiscal 2023.
  • Enovis Corp other nonoperating income (expense) for fiscal 2023 was $25.66M, a 1129.07% increase from fiscal 2022.
  • Enovis Corp other nonoperating income (expense) for fiscal 2022 was $2.09M.
Period endOther Nonoperating Income (Expense) 3 monthOther Nonoperating Income (Expense) 6 monthOther Nonoperating Income (Expense) 9 monthOther Nonoperating Income (Expense) 12 month
2026-07-03-$1.91M
10-Q · filed 2026-08-06
$1.36M
10-Q · filed 2026-08-06
$1.50M
derived: sum of 3 quarters · filed 2026-08-06
$1.95M
derived: sum of 4 quarters · filed 2026-08-06
2026-04-03$3.27M
10-Q · filed 2026-05-07
$3.41M
derived: sum of 2 quarters · filed 2026-05-07
$3.86M
derived: sum of 3 quarters · filed 2026-05-07
$4.30M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$141.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$589.00K
derived: sum of 2 quarters · filed 2026-02-26
$1.02M
derived: sum of 3 quarters · filed 2026-08-06
-$367.00K
10-K · filed 2026-02-26
2025-10-03$448.00K
10-Q · filed 2025-11-06
$884.00K
derived: sum of 2 quarters · filed 2026-08-06
-$508.00K
10-Q · filed 2025-11-06
-$416.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-07-04$436.00K
10-Q · filed 2026-08-06
-$956.00K
10-Q · filed 2026-08-06
-$864.00K
derived: sum of 3 quarters · filed 2026-08-06
-$662.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-04-04-$1.39M
10-Q · filed 2026-05-07
-$1.30M
derived: sum of 2 quarters · filed 2026-05-07
-$1.10M
derived: sum of 3 quarters · filed 2026-05-07
$32.74M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$92.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$294.00K
derived: sum of 2 quarters · filed 2026-02-26
$34.13M
derived: sum of 3 quarters · filed 2026-02-26
$9.89M
10-K · filed 2026-02-26
2024-09-27$202.00K
10-Q · filed 2025-11-06
$34.04M
derived: sum of 2 quarters · filed 2025-11-06
$9.80M
10-Q · filed 2025-11-06
$34.80M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-28$33.84M
10-Q · filed 2025-08-07
$9.60M
10-Q · filed 2025-08-07
$34.60M
derived: sum of 3 quarters · filed 2026-02-26
$35.36M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-29-$24.23M
10-Q · filed 2025-05-08
$763.00K
derived: sum of 2 quarters · filed 2026-02-26
$1.52M
derived: sum of 3 quarters · filed 2026-02-26
$767.00K
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$25.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$25.75M
derived: sum of 2 quarters · filed 2026-02-26
$25.00M
derived: sum of 3 quarters · filed 2026-02-26
$25.66M
10-K · filed 2026-02-26
2023-09-29$757.00K
10-Q · filed 2024-11-06
$4.00K
derived: sum of 2 quarters · filed 2024-11-06
$665.00K
10-Q · filed 2024-11-06
$2.45M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30-$753.00K
10-Q · filed 2024-08-07
-$92.00K
10-Q · filed 2024-08-07
$1.70M
derived: sum of 3 quarters · filed 2025-02-26
$2.00M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$661.00K
10-Q · filed 2024-05-02
$2.45M
derived: sum of 2 quarters · filed 2025-02-26
$2.75M
derived: sum of 3 quarters · filed 2025-02-26
$2.75M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$1.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$2.09M
derived: sum of 2 quarters · filed 2025-02-26
$2.09M
derived: sum of 3 quarters · filed 2025-02-26
$2.09M
10-K · filed 2025-02-26
2022-09-30$300.00K
10-Q · filed 2023-11-07
$300.00K
derived: sum of 2 quarters · filed 2023-11-07
$300.00K
10-Q · filed 2023-11-07
2022-07-01$0.00
10-Q · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
2021-12-31$0.00
10-K · filed 2024-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85